Enanta

$49.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.26 (-2.49%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Enanta and other stocks, options, and ETFs commission-free!

About ENTA

Enanta Pharmaceuticals, Inc. operates as a biotechnology company. It engages in the research and development of molecule drugs for the treatment of viral infections and liver diseases. The firm offers the medicine under the brands Mavyret and Viekira Pak. The company was founded by Peter O. Kliem and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA. The listed name for ENTA is Enanta Pharmaceuticals, Inc. Common Stock.

CEO
Jay R. Luly
Employees
141
Headquarters
Watertown, Massachusetts
Founded
1995
Market Cap
989.49M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
152.87K
High Today
$51.06
Low Today
$47.96
Open Price
$50.03
Volume
270.99K
52 Week High
$58.59
52 Week Low
$38.40

ENTA Earnings

-$1.46
-$0.76
-$0.05
$0.65
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected May 6, After Hours

You May Also Like

NPV
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure